Oral evidence transcript
| Published on: | Monday 10 March 2014 |
|---|---|
| Date: | Wednesday 5 March 2014 |
| Meeting on: | Wednesday 5 March 2014 |
| Part of event segment: | Untitled |
| Document ID: | 152950 |
| Citations: |
|
Committees
Work packages
-
Blood, tissue and organ screening
Saturday 30 November 2013 - Friday 17 October 2014
Witnesses
-
Dr Steven Burton, Chief Executive, ProMetic Biosciences Ltd, Dr Kelly Board, Technical Specialist, DuPont Chemicals and Fluoroproducts, Dr Alex Raeber, Head of Research and Development, Prionics AG, Nigel Talboys, Global Director of Blood Safety and EMEA Director of Public Policy and Government Affairs, Terumo BCT, and Professor John Collinge, Director, MRC Prion Unit and Professor of Neurology at the UCL Institute of Neurology.